Eone Diagnomics Genome Center Co., Ltd.

A245620

KR7245620000

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 04/04/2024 BST			5-day change	1st Jan Change
415 ^KRW	-5.25%		-.--%	-0.72%

04-16	Eone Diagnomics Genome Center Co., Ltd.(KOSDAQ:A245620) dropped from S&P Global BMI Index	CI
04-08	Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 20 billion in funding	CI

Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 20 billion in funding

April 07, 2024

On April 8, 2024, Eone Diagnomics Genome Center Co., Ltd. closed the transaction.

Latest news about Eone Diagnomics Genome Center Co., Ltd.

Eone Diagnomics Genome Center Co., Ltd.(KOSDAQ:A245620) dropped from S&P Global BMI Index	04-15	CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 20 billion in funding	04-07	CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 20 billion in funding	03-21	CI
Eone Diagnomics Genome Center Co., Ltd. acquired GDxLab, INC.	24/10/23	CI
Eone Diagnomics Genome Center to Raise 89.4 Billion Won via Stock Sale	21/08/23	MT
Eone Diagnomics Genome Center Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 6 billion in funding from Shinhan Financial Investment Co., Ltd., Samsung Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd.	26/04/22	CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Shinhan Financial Investment Co., Ltd., Samsung Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd.	21/04/22	CI
MarketScreener's World Press Review : April 11, 2022	11/04/22
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Investment Hanwha Healthcare Private Equity Fund Co. Ltd	09/12/21	CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Investment Hanwha Healthcare Private Equity Fund Co. Ltd	28/11/21	CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 30 billion in funding	28/10/21	CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 30 billion in funding	26/10/21	CI
Eone Diagnomics Genome Center Co., Ltd. acquired Natural Life Nutrition Inc.	27/07/21	CI
Maple Holdings Co., Ltd. announced that it has received KRW 25 billion in funding from Eone Diagnomics Genome Center Co., Ltd.	18/07/21	CI
Eone Diagnomics Genome Center Co.Ltd. agreed to acquire remaining 51.07% stake in EDGC Healthcare Co., Ltd for approximately KRW 140 billion.	24/05/20	CI
Eone Diagnomics Genome Center : South Korean test kit makers swamped as coronavirus cases explode in U.S., Europe	27/03/20	RE
Eone Diagnomics Genome Center Co.Ltd. announced that it has received KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., AJU IB INVESTMENT Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd.	30/06/19	CI
Eone Diagnomics Genome Center Co.Ltd. to Raise USD 17.2 Million in Private Placement of Bonds	24/06/19	CI
Eone Diagnomics Genome Center Co.Ltd. announced that it expects to receive KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., AJU IB INVESTMENT Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., and other investors	20/06/19	CI
Eone Diagnomics Genome Center Co.Ltd.(KOSDAQ:A245620) added to S&P Global BMI Index	24/12/18	CI
EONE-DIAGNOMICS Genome Center Announces the Release of Liquid Biopsy Screening Service	19/10/18	CI
Eone Diagnomics Genome Center Co.Ltd. acquired 49.9% stake in Cns Healthcare, Ltd from Kyungsook Im, Soonbae Cha and Yoonsoon Han.	29/09/18	CI
Eone Diagnomics Genome Center Co.Ltd. signed a definitive agreement to acquire 49.9% stake in Cns Healthcare, Ltd from Kyungsook Im, Soonbae Cha and Yoonsoon Han for KRW 19.7 billion.	03/09/18	CI
Eone Diagnomics Genome Center Co.Ltd. has completed an IPO in the amount of KRW 46.8 billion.	22/06/18	CI

Chart Eone Diagnomics Genome Center Co., Ltd.

Duration

Period

Chart Eone Diagnomics Genome Center Co., Ltd.

More charts

Eone Diagnomics Genome Center Co., Ltd. is a Korea-based company engaged in genetic analysis business. The Company is engaged in non-invasive prenatal tests (NIPT), newborn screening tests, ophthalmologist specialist genome analysis tests, customized disease prediction tests, and direct to consumer (DTC) genetic tests, among others. In addition, the Company is developing genome-related software.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
EONE DIAGNOMICS GENOME CENTER CO., LTD.	-0.72%	41.65M
CARDINAL HEALTH, INC.	-2.46%	23.95B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.23%	8.7B
SINOPHARM GROUP CO. LTD.	+1.47%	8.29B
HUADONG MEDICINE CO., LTD	-32.92%	6.7B
H. LUNDBECK A/S	+18.62%	5.38B
GALENICA AG	+1.10%	4.08B
EBOS GROUP LIMITED	-9.24%	3.79B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-10.20%	3.3B
MEDIPAL HOLDINGS CORPORATION	+7.11%	3.19B